-- U.S. RESEARCH ROUNDUP: Allergan, Broadcom
-- 
-- Tue Jun 03, 2014 05:26AM EDT
-- None



June 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allergan and Broadcom, on Tuesday.

HIGHLIGHTS * Allergan Inc <AGN.N>: Credit Suisse cuts to neutral from outperform * Broadcom Corp <BRCM.O>: SocGen, Jefferies, others raise target price on stock   Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.   * Allergan Inc <AGN.N>: Credit Suisse cuts to neutral from outperform * Broadcom Corp <BRCM.O>: SocGen raises target price to $36 from $30; rating hold * Broadcom Corp <BRCM.O>: Jefferies raises target price to $44 from $37; rating buy * Broadcom Corp <BRCM.O>: Barclays raises price target to $28 from $23; rating underweight * CBOE Holdings Inc <CBOE.O>: Barclays cuts target to $46 from $48; rating equal weight * Conn's Inc <CONN.O>: Canaccord Genuity raises target price to $71 from $60; rating buy * Ecolab Inc <ECL.N>: Oppenheimer raises target price to $129 from $113; rating outperform * United Stationers <USTR.O>: Jefferies raises target price to $39 from $36; rating hold